1 month Stocks making the biggest premarket moves: Eli Lilly, Paramount Global, Hawaiian Holdings and more CNBC Names on the move ahead of the open. Eli Lilly (LLY) · Premarket
1 day BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPOInvestor's Business Daily
1 week Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher TodayThe Motley Fool
1 week DJT stock price update: Trump Media shares continue to sink after lockup period expiresFast Company
1 week Cracker Barrel’s earnings fall short as it works to draw customers back to its stores and restaurantsMarketWatch
1 week Stocks making the biggest moves premarket: Darden Restaurants, Nvidia, DoorDash, Coursera and moreCNBC
1 week Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest InInsider Monkey
1 week This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly’s Weight-Loss TreatmentsThe Motley Fool
1 week This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk’s and Eli Lilly’s Weight Loss TreatmentsThe Motley Fool
1 week Stocks making the biggest moves premarket: General Mills, U.S. Steel, V.F. Corp., ResMed, and moreCNBC
2 weeks Drugmakers bet billions that targeted radiation could become the next cancer breakthroughCNBC
2 weeks World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, ModernaYahoo Finance
2 weeks Boeing workers to go on strike as union rejects labor deal; shares fall premarketInvesting.com
2 weeks Stocks making the biggest moves premarket: Moderna, Alaska Air, Oxford Industries and moreCNBC
2 weeks Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right NowYahoo Finance
2 weeks Roche stock is falling after report its Wegovy challenger is causing patients to vomitFortune
2 weeks Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes, Alzheimer’s drugsCNBC
2 weeks DJT stock price today: Truth Social parent Trump Media is having a post-debate hangoverFast Company
2 weeks Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I’m Not Talking About Zepbound)The Motley Fool
3 weeks Summit Therapeutics’ stock pops as lung-cancer treatment beats Merck blockbuster in late-stage trialMarketWatch
3 weeks Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli LillyThe Motley Fool
3 weeks Jim Cramer Says Eli Lilly and Company (LLY) Has the Biggest Pharmaceutical PotentialInsider Monkey
3 weeks Does Eli Lilly and Company (LLY)’s Financial Performance Make It A Safe Stock To Invest In Now?Insider Monkey
3 weeks This Big Move by Eli Lilly May Solve the Weight Loss Drug Market’s Biggest ProblemYahoo Finance
3 weeks Eli Lilly and Company (LLY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
3 weeks Eli Lilly Just Made Zepbound Even More Appealing. Here’s What Smart Investors Need to Know.The Motley Fool
3 weeks How Lilly, Novo Could Beat Tesla To The Trillion-Dollar Club; Plus, Nvidia’s Battle With Microsoft, AppleInvestor's Business Daily
3 weeks Eli Lilly Trades Near All-Time High: Check Out The IBD 50, Big Cap 20, Other Top Stock ListsInvestor's Business Daily